BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 32473151)

  • 21. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
    Zhao Y; Yin L; Patel J; Tang L; Huang Y
    J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
    Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
    Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
    Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.
    Bao J; Li C; Zhang K; Kang H; Chen W; Gu B
    Clin Chim Acta; 2020 Oct; 509():180-194. PubMed ID: 32511971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of time-normalized laboratory findings in predicting COVID-19 outcome.
    Ferrari D; Seveso A; Sabetta E; Ceriotti D; Carobene A; Banfi G; Locatelli M; Cabitza F
    Diagnosis (Berl); 2020 Nov; 7(4):387-394. PubMed ID: 33035183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
    Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
    BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China.
    Xu JB; Xu C; Zhang RB; Wu M; Pan CK; Li XJ; Wang Q; Zeng FF; Zhu S
    Sci Rep; 2020 Sep; 10(1):15058. PubMed ID: 32929124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis.
    Henry BM; Aggarwal G; Wong J; Benoit S; Vikse J; Plebani M; Lippi G
    Am J Emerg Med; 2020 Sep; 38(9):1722-1726. PubMed ID: 32738466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.
    Kim L; Whitaker M; O'Halloran A; Kambhampati A; Chai SJ; Reingold A; Armistead I; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Weigel A; Ryan P; Monroe ML; Fox K; Kim S; Lynfield R; Bye E; Shrum Davis S; Smelser C; Barney G; Spina NL; Bennett NM; Felsen CB; Billing LM; Shiltz J; Sutton M; West N; Talbot HK; Schaffner W; Risk I; Price A; Brammer L; Fry AM; Hall AJ; Langley GE; Garg S;
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1081-1088. PubMed ID: 32790664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.
    Zhao K; Li R; Wu X; Zhao Y; Wang T; Zheng Z; Zeng S; Ding X; Nie H
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2279-2287. PubMed ID: 32651736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
    Lippi G; Plebani M
    Clin Chim Acta; 2020 Jun; 505():190-191. PubMed ID: 32145275
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Moutchia J; Pokharel P; Kerri A; McGaw K; Uchai S; Nji M; Goodman M
    PLoS One; 2020; 15(10):e0239802. PubMed ID: 33002041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of 71 patients with coronavirus disease 2019.
    Xiao M; Hou M; Liu X; Li Z; Zhao Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):790-796. PubMed ID: 32879082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
    Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
    J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild versus severe COVID-19: Laboratory markers.
    Velavan TP; Meyer CG
    Int J Infect Dis; 2020 Jun; 95():304-307. PubMed ID: 32344011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of COVID-19: Changes in laboratory parameters.
    Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
    Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study.
    Soliman AT; Prabhakaran Nair A; Al Masalamani MS; De Sanctis V; Abu Khattab MA; Alsaud AE; Sasi S; Ali EA; Ola A H; Iqbal FM; Nashwan AJ; Fahad J; El Madhoun I; Yassin MA
    Acta Biomed; 2020 Sep; 91(3):e2020010. PubMed ID: 32921708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.